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doi:10.1016/j.pedneo.2011.08.003Objective: The increasing incidence of pediatric Crohn’s disease (CD) is well known in Western
countries in the last two decades. This study was conducted to delineate the trends of inci-
dence during this period and clinical patterns of pediatric CD in Taiwan.
Methods: All children admitted to National Taiwan University Hospital between 1990 and 2009
who met the Porto Criteria for CD were included. Annual enrollment and clinical characteris-
tics were retrospectively reviewed. The incidence was calculated by dividing the number of
index cases by total hospitalized pediatric cases to minimize the bias caused by the growing
number of hospitalized patients there. We quoted data and statistics from the Department
of Health, Executive Yuan, Taiwan, and Accounting and Statistics, Executive Yuan, Taiwan,
to present the social-economic changes in Taiwan in the recent decades.
Results: The cumulative hospital-based incidence of CD rose from 13.2 per 100,000 to 25.4 per
100,000 children admitted to this hospital in the past two decades. The median age of diag-
nosis in the first decade of this study was less than that of the second decade. The other study
parameters, including gender, disease activity at diagnosis, duration from disease onset to
diagnosis, anatomic location and disease behavior, and symptoms at diagnosis, were not
different.
Conclusions: This study showed that the hospital-based incidence of pediatric CD has been
increasing in Taiwan in recent decades. Factors contributing to such an increase could be
physicians’ awareness of the disease, easier access to health care, and environmental factors.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.t of Pediatrics, National Taiwan University Children’s Hospital, National Taiwan University, No. 8,
aiwan.
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318 Y.-M. Shen et al1. Introduction 2.1. Statistical analysisThe incidence of Crohn’s disease (CD) in adults has
increased throughout the 1950s and 1970s, especially in
North America, the United Kingdom, and northwestern
Europe.1,2 Recent data suggest that this trend of increase
has reached a plateau in most medical centers, with an
annual incidence of 5e7 per 100,0001 in the Western world.
Some studies have suggested that the incidence of pediatric
CD is increasing in America, Europe, and Australia.3e11 In
Scotland, the incidence in children aged 16 years or
younger rose from 2.29 to 4.2 per 100,000 between 1983
and 2001.11 In Australia, the incidence of CD in children
aged 16 years or younger rose from 0.128 to 2.0 per 100,000
per year over the three decades.10 There is limited infor-
mation on the incidence of pediatric CD in the other parts
of the world. In our hospital, we have observed an
increasing number of pediatric CD cases. This study was
conducted to delineate the trends in hospital-based inci-
dence and clinical patterns of pediatric CD in Taiwan, an
Asian country.
2. Methods
We reviewed all pediatric patients admitted to National
Taiwan University Hospital, aged 18 years or younger, over
a 20-year period (1990e2009). Those children whose clin-
ical features retrospectively met the Porto Criteria12 for CD
were included.
Annual enrollment and clinical characteristics were
retrospectively evaluated by medical record review.
Patients were divided into two groups according to the
years of diagnosis: Group 1Z from 1990 to 1999 and Group
2Z from 2000 to 2009. The incidence was calculated by
dividing the number of index cases by total hospitalized
pediatric cases to eliminate the bias caused by the growing
number of patients of this hospital. Disease activity was
assessed by the Pediatric Crohn’s Disease Activity Index
(PCDAI).13 Inactive, mild, moderate, and severe diseases
were defined as PCDAI score 15, 15< PCDAI score 30,
30< PCDAI score 45, and PCDAI score> 45, respec-
tively.14,15 Growth retardation was defined in the following
ways: (1) by a static measurement of height/weight below
the third percentile; (2) by evidence of significant growth
change as assessed over time by percentile chart analysis
(i.e. a shift from higher to lower percentiles of height/
weight attained); and (3) by showing a reduction in height
velocity <2.0 standard-deviation scores.16 Data were
collected and analyzed regarding gender, disease activity
at diagnosis, age at disease onset, duration from disease
onset to diagnosis, anatomic location and disease behavior,
signs and symptoms at diagnosis, family history, and delay
in sexual development.
We quoted the data and statistics from the Bureau of
National Health Insurance, Department of Health, Executive
Yuan, Taiwan; Directorate-General of Budget, Accounting
and Statistics, Executive Yuan, Taiwan; and Food and Drug
Administration, Department of Health, Executive Yuan,
Taiwan, to present the social-economic changes in Taiwan
in recent decades.Differences in proportions of patients with different clinical
characteristics were assessed using Fisher’s exact test.
Rank-sum test was used to compare group quantitative
data. A p value <0.05 was considered to represent statis-
tical significance. All statistical analyses were performed
using SPSS version 8.0 (SPSS Inc., Chicago, IL, USA).
3. Results
Twenty-seven pediatric patients were identified and met
the Porto Criteria12 from 1990 to 2009 in this hospital. The
numbers of cases of pediatric CD were 7 in Group 1 and 20
in Group 2. The cumulative hospital-based incidence of CD
rose from 13.2 per 100,000 to 25.4 per 100,000 children
admitted to this hospital. The patient demographics and
duration from disease onset to diagnosis in CD are
summarized in Table 1. The age at diagnosis in Group 1 was
less than that in Group 2 (pZ 0.03) by rank-sum test. The
gender distribution was similar between the groups
(pZ 1.0) by Fisher’s exact test. The disease activity at
diagnosis was similar between the groups (pZ 0.76) by
Fisher’s exact test. No significant difference in the duration
from disease onset to diagnosis was noted between the
groups (pZ 0.96) by rank-sum test. According to the
Montreal classification,17 there was no difference in disease
location (pZ 0.55) and disease behavior (pZ 0.26)
between the groups by Fisher’s exact test (Table 2). Both
groups had two patients presenting with failure to thrive.
One patient in Group 1 had a family history of CD (grand-
mother). There was a pair of twin patients in Group 2. The
initial presentation of pediatric CD, including diarrhea,
vomiting, bloody stools, abdominal pain, weight loss, fever,
and extragastrointestinal manifestations, was similar
between the two groups by Fisher’s exact test.
Taiwan has experienced many social-economic changes
in the recent decades. National Health Insurance (NHI) in
Taiwan has been operating since 1995. About 99% of the
total population in Taiwan is covered by NHI. The medical
services became very convenient and affordable after NHI
implementation. The cumulative incidence of pediatric CD
before NHI implementation (1990e1994) was 4.6 per
100,000 children admitted to this hospital, and the cumu-
lative pediatric CD incidence after NHI implementation
(1995e2009) was 23.6 per 100,000 children admitted to
this hospital. In the period postimplementation of NHI,
there is still an increasing-incidence trend. The cumulative
incidence in pediatric CD was 19.1 per 100,000 children
admitted to this hospital in 1995e1999 and 25.4 per 100,000
children admitted to this hospital in 2000e2009.
According to the statistics from the Directorate-General
of Budget, Accounting and Statistics, Executive Yuan,
Taiwan, the per capita income in Taiwan was US$7622 in
1990 and US$14,453 in 2009. The per capita income in
Taiwan has almost doubled in the past two decades. The
environment factors, such as hygiene, have also changed
a lot during that period. The Nutrition and Health Survey in
Taiwan, directed by Food and Drug Administration,
Department of Health, Executive Yuan, Taiwan, revealed
Table 1 Patient demographics and duration from disease onset to diagnosis of Crohn’s disease.
Characteristics Group 1 (nZ 7) Group 2 (nZ 20) p
Gender 1.0
Male 4 (57.1%) 12 (60%)
Female 3 (42.9%) 8 (40%)
Male:female ratio 1.3:1 1.5:1
PCDAI score at diagnosis 0.76
No activity (PCDAI score 15) 0 (0%) 1 (5%)
Mild (15< PCDAI score 30) 1 (14.3%) 6 (30%)
Moderate (30< PCDAI score 45) 3 (42.8%) 6 (30%)
Severe (PCDAI score> 45) 3 (42.8%) 7 (35%)
Median age at diagnosis (y) 7.83 (5.42e15.83) 12.5 (2.5e17.83) 0.03
Duration from disease onset to diagnosis (mo) 4 (1e36) 5 (1e47) 0.96
mo Z months; PCDAIZ Pediatric Crohn’s Disease Activity Index; y Z years.
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group from 1993e1996 to 2001e2002.
4. Discussion
Our data confirmed increased numbers in newly diagnosed
pediatric CD in this hospital in recent years. An almost
twofold increase in hospital-based incidence of the disease
was noted. Factors contributing to such increase could
be physicians’ awareness of the disease, easier access
to health care, and environmental factors. In our study,
patients with no disease activity and mild disease activity
at diagnosis included one (14%) in Group 1 and seven (35%)
in Group 2. An increase of physicians’ awareness of pedi-
atric CD may play a role in the increasing numbers of
pediatric CD cases in our hospital. Easy access to health
care and affordable medical service after NHI imple-
mentation play roles in the trend of increasing incidence in
Taiwan. This trend continued even after the establishment
of NHI. It was reported that refined sugar consumption,
increase in fat intake, and decrease in fiber consumption
increase the risk of CD.18 The Nutrition and Health Survey in
Taiwan, directed by Food and Drug Administration,Table 2 Anatomic location and disease behavior accord-
ing to Montreal classification.
Characteristics Group 1 Group 2 p
Location 0.55
L1, ileal 1 (14.3%) 3 (15%)
L2, colonic 1 (14.3%) 7 (35%)
L3, ileocolonic 5 (71.4%) 10 (50%)
L4, isolated upper disease 0 (0%) 0 (0%)
Behavior 0.26
B1, nonstricturing,
nonpenetration
5 (71.4%) 10 (50%)
B2, stricturing 0 (0%) 6 (30%)
B3, penetration 2 (28.6%) 4 (20%)
P, perianal disease modifier 0 4 (20%)Department of Health, Executive Yuan, Taiwan, revealed
increased energy-rich diet and obesity in the pediatric
group from 1993e1996 to 2001e2002. The change in diet
and increased incidence of obesity may play a role in the
increasing incidence of pediatric CD in Taiwan. Exposure
to poor hygiene or an increased potential for infections
during childhood was considered as conferring protection
against CD later in life.19 This phenomenon has been well
established for pediatric and adult asthma and is being
postulated for various autoimmune diseases. The possible
underlying cause is that early childhood infections help
establish the immunological balance between proin-
flammatory and tolerance-inducing regulatory T cells,
preventing subsequent unfavorable responses to allergen,
microbial, or other antigenic stimuli.19 Here in Taiwan,
hygiene improvement and the control of infectious diseases
as the economy blossoms may contribute to the increasing
incidence of pediatric CD in Taiwan.
In our study, the age at diagnosis was lesser in Group 1
than that in Group 2. Because there was no difference in
the duration from disease onset to diagnosis, the diagnosis
of CD at older age for Group 2 cannot be attributed to
delayed diagnosis. The age at diagnosis of pediatric CD was
mainly school age, such as 14.3 years in Canada,6 13.7 years
in Norway,20 and 11.5 years in Italy.7 In our study, the
median age at diagnosis in Group 1 was 7.83 years, which is
less than that reported from previous studies, and this
phenomenon may be the result of the different genetic
backgrounds. The median age at diagnosis in Group 2 was
12.5 years, which is similar to those of studies in the
Western world, and this phenomenon may be the result of
the westernization of life in Taiwan in recent decades.
5. Conclusion
In summary, our study provides insight into the hospital-
based incidence of pediatric CD in Taiwan, which may
reflect an increasing incidence of pediatric CD. The
increasing trends of pediatric CD are parallel in both
hemispheres. Future studies, preferably prospective, are
necessary to further clarify the risk factors and pathogen-
esis of CD.
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